Expanding Global Footprint Tjoapack's recent expansion in both North America and Europe, including the addition of a large GMP facility in Tennessee, presents significant opportunities for pharmaceutical companies seeking reliable packaging and supply chain partners with regional presence and increased capacity.

Diverse Packaging Capabilities Specializing in primary and secondary packaging for a broad range of pharmaceutical products including biotech, clinical trial, controlled substances, and orphan drugs, Tjoapack can support clients across multiple therapeutic areas and complex packaging needs.

Technological Advancements With innovative tools like their customer Dashboard and advanced serialization and aggregation capabilities, Tjoapack enhances transparency and supply chain security, offering a value proposition for clients focused on compliance and real-time tracking.

Strategic Investment & Ownership Backed by Ampersand Capital since 2020 and now potentially joining Alcami Corporation, Tjoapack’s strong financial backing and industry alliances indicate stability and growth potential, making it an attractive partner for pharmaceutical companies looking for scalability.

Regulatory Certifications Holding both EU-GMP and FDA certifications, Tjoapack is well-positioned to serve clients targeting global markets, especially those requiring strict compliance and quality assurance in their packaging and supply chain operations.